Latest Asx News

Jameson Resources has secured A$3 million through a discounted share placement to advance critical environmental approvals and Indigenous engagement for its Crown Mountain coal project in British Columbia, aiming to submit the final application by late 2026.

Red Sky Energy has locked in a binding agreement with Santos to drill the Willowie appraisal well in South Australia’s Innamincka Dome, aiming to build on recent production gains and accelerate cashflow.

Pro Medicus has secured a 5-year, A$37 million contract renewal with Northwestern Medicine, featuring higher minimum usage commitments and increased fees per transaction, reflecting growth in exam volumes.

Southern Cross Gold Consolidated Ltd. has transitioned its Sunday Creek project into execution, commencing surface works and targeting a maiden inferred resource in early 2027, supported by a robust $123.2 million cash position.

Stavely Minerals has locked in A$4 million through a heavily oversubscribed placement, backing its upcoming Thursday’s Gossan Scoping Study and exploration programs. The raise underscores investor confidence ahead of key milestones.

EMVision Medical Devices has ramped up recruitment in its pivotal FDA trial across eight hospitals and is nearing results from multiple pre-hospital studies, all while bolstering its cash position with a $3.8 million R&D tax refund and $6.6 million in grant funding.

Rimfire Pacific Mining has boosted its Murga Scandium Deposit resource by 300%, lifting the inferred mineral resource to 56.1 million tonnes at 138ppm scandium. The deposit’s low iron content hints at potential cost savings via atmospheric leaching, with follow-up drilling and metallurgical tests slated for mid-2026.

Prairie Lithium is poised to begin commercial lithium production in Q4 2026 as its Direct Lithium Extraction facility nears completion, backed by a binding offtake agreement covering 100% of Phase 1 output and a strategic AU$10 million equipment contribution from Hydro Lithium.

Argent BioPharma has finalized the acquisition of CannPal Animal Therapeutics, securing a Phase 3 veterinary epilepsy asset with near-term commercial prospects and an option to acquire the Neuvis® drug delivery platform, enhancing its neurological portfolio and U.S. market ambitions.

Diatreme Resources is consolidating its Far North Queensland silica assets by selling the Cape Flattery Silica Project to its joint venture with Sibelco, securing $7.4 million in fresh capital and streamlining project ownership ahead of key development milestones.

Kingsgate Consolidated delivered over 21,000 ounces of gold in the March quarter, marking its fifth consecutive quarter above this threshold, while cash reserves rose nearly 20% to A$213 million.

Monash IVF has received a revised $0.90 per share acquisition proposal from a consortium led by Genesis Capital and WHSP Holdings, upping the ante from a previous $0.80 offer. The deal hinges on exclusivity and unanimous board support, with no guarantee of completion.